Type
1.
Grant A, Alter A, Huong NT, Orlova M, Van Thuc N, Ba NN, et al. Crohn’s disease susceptibility genes are associated with leprosy in the Vietnamese population. The Journal of infectious diseases. 2012;206(11):1763-7.
Type
1.
Anusuya S, Natarajan J. Multi-targeted therapy for leprosy: insilico strategy to overcome multi drug resistance and to improve therapeutic efficacy. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2012;12(8):1899-910.
Type
1.
Lira KB, Leite JJG, Maia DCBSC, Freitas RMF, Feijão AR. Knowledge of the patients regarding leprosy and adherence to treatment. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2012;16(5):472-5.
Type
1.
Scarlata F, Imburgia C, Trizzino M, Titone L. [Leprosy-like cutaneous presentation of Histoplasma capsulatum infection in an African HIV+ patient]. Le infezioni in medicina. 2012;20(3):211-3.
Type
1.
Hacker MAVB, Sales AM, Albuquerque ECA, Rangel E, Costa Nery JA, Duppre NC, et al. [Patients from a reference center for leprosy: Rio de Janeiro and Duque de Caxias, 1986-2008]. Ciencia & saude coletiva [Internet]. 2012;17(9):2533-41. Available from: http://www.scielo.br/pdf/csc/v17n9/a33v17n9.pdf
Type
1.
Nardi SMT, Paschoal VD, Zanetta DMT. Limitations in activities of people affected by leprosy after completing multidrug therapy: application of the SALSA scale. Leprosy review [Internet]. 2012;83(2):172-83. Available from: https://leprosyreview.org/article/83/2/12-1719
Type
1.
Larrea MR, Carreño MC, Fine PE. Patterns and trends of leprosy in Mexico: 1989-2009. Leprosy review [Internet]. 2012;83(2):184-94. Available from: https://leprosyreview.org/article/83/2/12-1715
Type
1.
Cross H. The prevention of leprosy related disability as an integral component of the government health delivery programme in Myanmar. Leprosy review [Internet]. 2012;83(2):205-17. Available from: https://leprosyreview.org/article/83/2/12-1723
Type
1.
Walker SL Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK, Nicholls PG, Dhakal S, Hawksworth R, Macdonald M, Mahat K, et al. A comparison of the change in clinical severity scale score and a retrospective physician assessment of neurological outcome in individuals with leprosy associated nerve function impairment after treatment with corticosteroids. Leprosy review [Internet]. 2012;83(2):154-63. Available from: https://leprosyreview.org/article/83/2/12-1685
Type
1.
Griffiths M. ’Double mainstreaming’: including people affected by leprosy in poverty reduction programmes. Leprosy review [Internet]. 2012;83(2):124-6. Available from: https://leprosyreview.org/article/83/2/12-1771
Pagination
- Previous page
- Page 396
- Next page